Universitat de Barcelona (UB) / University of Barcelona

LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ARTERITIS: RESULTS FROM PART 2 OF THE GIACTA TRIAL (2019) Stone JH, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis (2019) Gambato M, Canini L, Lens S, Graw F, Perpinan E, Londono MC, Uprichard SL, et al. Journal article EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN THE GIACTA TRIAL (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Long-term obeticholic acid treatment is associated with improvements in collagen morphometry in patients with primary biliary cholangitis (2019) Kremer A, Bowlus C, Bedossa P, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE (2019) Wong L, Mescia F, Alberici F, Ball MJ, Baslund B, Brenchley P, Bruchfeld A, et al. Conference contribution EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL (2019) Stone J, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution sPlot – A new tool for global vegetation analyses (2019) Bruelheide H, Dengler J, Jiménez-Alfaro B, Purschke O, Hennekens SM, Chytrý M, Pillar VD, et al. Journal article Observatory science with eXTP (2019) In'T Zand JJM, Bozzo E, Qu J, Li XD, Amati L, Chen Y, Donnarumma I, et al. Journal article Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy (2019) Bowlus CL, Pockros PJ, Kremer A, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, et al. Journal article